Noa Davis

Noa Davis has worked in a variety of roles in the medical and research sectors. Noa began their career in 2008 as a research associate at Tel Aviv University. In 2011, they joined Micromedic as R&D Director and Project Manager. In 2017, they were appointed CSO of Prize4Life. In 2018, they were appointed Head of Drug Development and Medical Cannabis Researcher at IPTM. In 2021, they became Clinical Research Manager at Biomica Ltd. and in 2022 they were appointed Senior Manager of Clinical and Regulatory Affairs at CAPS Medical.

Noa Davis completed a Bachelor of Science in Life Science at The Hebrew University of Jerusalem between 1996 and 1998. Noa then obtained a Master of Science in Genetics at Tel Aviv University between 1999 and 2001. Finally, they obtained a Doctor of Philosophy in Genetics at Tel Aviv University between 2002 and 2008.